GR76518B - - Google Patents
Info
- Publication number
- GR76518B GR76518B GR67455A GR820167455A GR76518B GR 76518 B GR76518 B GR 76518B GR 67455 A GR67455 A GR 67455A GR 820167455 A GR820167455 A GR 820167455A GR 76518 B GR76518 B GR 76518B
- Authority
- GR
- Greece
- Prior art keywords
- aroylimidazole
- cardiotonics
- ones
- acid
- treatment
- Prior art date
Links
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000000496 cardiotonic agent Substances 0.000 abstract 1
- 230000003177 cardiotonic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Luminescent Compositions (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24088981A | 1981-03-05 | 1981-03-05 | |
| US06/314,312 US4405628A (en) | 1981-03-05 | 1981-10-23 | 4-Pyridylimidazolones and method of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR76518B true GR76518B (enExample) | 1984-08-10 |
Family
ID=26933806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR67455A GR76518B (enExample) | 1981-03-05 | 1982-03-02 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4405628A (enExample) |
| EP (1) | EP0059948B1 (enExample) |
| KR (1) | KR890000765B1 (enExample) |
| AT (1) | ATE16489T1 (enExample) |
| AU (1) | AU557590B2 (enExample) |
| CA (1) | CA1190550A (enExample) |
| DE (1) | DE3267352D1 (enExample) |
| DK (1) | DK168627B1 (enExample) |
| ES (2) | ES510087A0 (enExample) |
| GB (1) | GB2096600B (enExample) |
| GR (1) | GR76518B (enExample) |
| HK (1) | HK61686A (enExample) |
| IE (1) | IE52387B1 (enExample) |
| IL (1) | IL65137A (enExample) |
| MY (1) | MY8600700A (enExample) |
| NO (1) | NO157175C (enExample) |
| NZ (1) | NZ199885A (enExample) |
| PH (1) | PH18345A (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4367236A (en) * | 1981-11-04 | 1983-01-04 | Merrell Dow Pharmaceuticals Inc. | Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives |
| US4552880A (en) * | 1983-02-15 | 1985-11-12 | Merrell Dow Pharmaceuticals Inc. | Aroylimidazolones |
| US4532250A (en) * | 1983-11-23 | 1985-07-30 | American Hospital Supply Corporation | 5-Heteroarylimidazol-2-ones having cardiotonic activity |
| US4556665A (en) * | 1984-07-09 | 1985-12-03 | Schering A.G. | Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones |
| US4803278A (en) * | 1984-07-30 | 1989-02-07 | Merrell Dow Pharmaceuticals, Inc. | Preparation of 1,3-dihydro-4-pyridoyl-2H-imidazol-2-ones |
| CA1262732C (en) * | 1984-07-30 | 1989-11-07 | PREPARATION OF 1,3-DIHYDRO-4-PYRIDOYL-2H-IMIDAZOL-2-ONES | |
| ZA881807B (en) * | 1987-03-20 | 1988-09-05 | Merrell Dow Pharmaceuticals Inc. | Method for reducing reperfusion injury with imidazol-2-thiones |
| US4999365A (en) * | 1987-03-20 | 1991-03-12 | Merrell Dow Pharmaceuticals Inc. | Method of reducing reperfusion injury with imidazol-2-thiones |
| ZA887662B (en) * | 1987-10-19 | 1989-06-28 | Merrell Dow Pharma | Method for reducing reperfusion injury with imidazol-2-thione-carboxamides |
| WO1992000282A1 (en) * | 1990-06-29 | 1992-01-09 | The Upjohn Company | Substituted 1-(alkoxyphenyl)piperazines with cns and antihypertensive activity |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| JP2011522828A (ja) | 2008-06-04 | 2011-08-04 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
| JP2011528375A (ja) | 2008-07-16 | 2011-11-17 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CA3100941C (en) | 2011-03-01 | 2024-03-05 | Synergy Pharmaceuticals Inc. | Process of preparing guanylate cyclase c agonists |
| HK1218629A1 (zh) | 2013-02-25 | 2017-03-03 | Bausch Health Ireland Limited | 用於结肠清洁的鸟苷酸环化酶受体激动剂 |
| AU2014235215A1 (en) | 2013-03-15 | 2015-10-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| EP2968439A2 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| WO2014197720A2 (en) | 2013-06-05 | 2014-12-11 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
| US20160184387A1 (en) | 2013-08-09 | 2016-06-30 | Dominique Charmot | Compounds and methods for inhibiting phosphate transport |
| CN114340631A (zh) | 2019-05-21 | 2022-04-12 | 阿德利克斯股份有限公司 | 用于降低患者的血清磷酸盐的组合 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2441933A (en) * | 1945-07-30 | 1948-05-18 | Hoffmann La Roche | Substituted imidazolones and process of making them |
| US3538104A (en) * | 1969-02-28 | 1970-11-03 | Geigy Chem Corp | Pyridyl-2-imidazolones |
| NZ193935A (en) * | 1979-06-18 | 1985-05-31 | Richardson Merrell Inc | 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions |
| ZA803332B (en) * | 1979-06-18 | 1981-01-28 | Richardson Merrell Inc | Novel 4-aroylimidazol-2-ones |
| PH18106A (en) * | 1981-02-18 | 1985-03-21 | Merrell Dow Pharma | Novel-4-aroylimidazol-2-ones |
-
1981
- 1981-10-23 US US06/314,312 patent/US4405628A/en not_active Expired - Lifetime
-
1982
- 1982-03-01 PH PH26929A patent/PH18345A/en unknown
- 1982-03-01 CA CA000397351A patent/CA1190550A/en not_active Expired
- 1982-03-01 IL IL65137A patent/IL65137A/xx not_active IP Right Cessation
- 1982-03-02 AU AU81037/82A patent/AU557590B2/en not_active Ceased
- 1982-03-02 GR GR67455A patent/GR76518B/el unknown
- 1982-03-02 NZ NZ199885A patent/NZ199885A/en unknown
- 1982-03-03 ES ES510087A patent/ES510087A0/es active Granted
- 1982-03-04 DK DK095482A patent/DK168627B1/da not_active IP Right Cessation
- 1982-03-04 AT AT82101706T patent/ATE16489T1/de active
- 1982-03-04 KR KR8200933A patent/KR890000765B1/ko not_active Expired
- 1982-03-04 DE DE8282101706T patent/DE3267352D1/de not_active Expired
- 1982-03-04 IE IE491/82A patent/IE52387B1/en not_active IP Right Cessation
- 1982-03-04 EP EP82101706A patent/EP0059948B1/en not_active Expired
- 1982-03-04 GB GB8206412A patent/GB2096600B/en not_active Expired
- 1982-03-04 NO NO820686A patent/NO157175C/no unknown
-
1983
- 1983-01-25 ES ES519254A patent/ES519254A0/es active Granted
-
1986
- 1986-08-21 HK HK616/86A patent/HK61686A/xx not_active IP Right Cessation
- 1986-12-30 MY MY700/86A patent/MY8600700A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB2096600B (en) | 1985-06-05 |
| NZ199885A (en) | 1985-04-30 |
| ES8402827A1 (es) | 1984-03-01 |
| GB2096600A (en) | 1982-10-20 |
| DK95482A (da) | 1982-09-06 |
| AU557590B2 (en) | 1986-12-24 |
| US4405628A (en) | 1983-09-20 |
| DK168627B1 (da) | 1994-05-09 |
| AU8103782A (en) | 1982-09-09 |
| EP0059948A1 (en) | 1982-09-15 |
| DE3267352D1 (en) | 1985-12-19 |
| IE820491L (en) | 1982-09-05 |
| PH18345A (en) | 1985-06-05 |
| NO157175B (no) | 1987-10-26 |
| EP0059948B1 (en) | 1985-11-13 |
| ATE16489T1 (de) | 1985-11-15 |
| HK61686A (en) | 1986-08-29 |
| IE52387B1 (en) | 1987-10-14 |
| NO820686L (no) | 1982-09-06 |
| NO157175C (no) | 1988-02-03 |
| KR890000765B1 (ko) | 1989-04-05 |
| ES8305352A1 (es) | 1983-04-16 |
| ES519254A0 (es) | 1984-03-01 |
| IL65137A0 (en) | 1982-05-31 |
| IL65137A (en) | 1987-02-27 |
| CA1190550A (en) | 1985-07-16 |
| MY8600700A (en) | 1986-12-31 |
| KR830009046A (ko) | 1983-12-17 |
| ES510087A0 (es) | 1983-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3267352D1 (en) | Novel aroylimidazolones | |
| DK505983A (da) | Imidazolylalkylthienyl-tetrahydropyridaziner og fremgangsmaade til fremstilling deraf | |
| ATE7387T1 (de) | Herstellung des calciumsalzes von alpha-hydroxy- gamma-methylmercaptobuttersaeure. | |
| JPS57122085A (en) | Circulatory disease extirpenter and use | |
| IE822519L (en) | Phosphonic acid derivatives | |
| NO864514D0 (no) | Fremgangsmaate for fremstilling av thiazoloner. | |
| ES530677A0 (es) | Procedimiento de laminado universal integral de perfilados metalicos del tipo vigueta en h o i | |
| DE3462688D1 (en) | 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases | |
| ATE79615T1 (de) | Cardiotonische phenyloxazolone. | |
| IT8519042A0 (it) | Impiego di chinoloni nel trattamento di malattie cardiache.! | |
| DE3373978D1 (en) | Composition for the care or treatment of the human skin | |
| GR75239B (enExample) | ||
| GR77250B (enExample) | ||
| DE3776488D1 (enExample) | ||
| IT8324141A0 (it) | Preparato per la cura delle ustioni. | |
| FI871737A0 (fi) | Kraftanlaeggning med foerbraenning i en fluidiserad baedd. |